Form 6-K Galmed Pharmaceuticals For: Mar 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Galmed Pharma (GLMD) Misses Q4 EPS by 1c
March 22, 2016 7:38 AM EDTGalmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
... More